📰 E Ltd News
Page 4 - E Ltd News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from E Ltd. Real-time updates on events, politics, business and more.
September 13, 2022
Cape Town: Afrigen Biologics Vaccines plans to start human trials of its Covid 19 vaccine candidate by May, part of a World Health Organisation back...
August 13, 2022
In second week of August 2022, the only notable startup funding was that of 210 million dollars raised by the EdTech startup, UpGrad
August 11, 2022
Corbevax was also approved by the Union Health Ministry as a heterologous COVID-19 booster dose under emergency use authorization for individuals aged 18 years and above after 6 months of administration of primary vaccination (two doses) of Covaxin or Covishield, the company said.
August 8, 2022
Eyestem will use the capital to solidify its cell therapy platform and conduct early clinical trials of its patented product
June 8, 2022
As the Covid cases slumped last month, most of the parents threw caution to wind and didn’t get their kids vaxxed. The preceding state can be statistically verified as Mumbai stands at 36 position in the state, when it comes to inoculating children in the 12 to 14 age group.
June 4, 2022
The Drug Controller General of India has approved Biological E's Corbevax as a heterologous Covid-19 booster dose.
June 4, 2022
This means that those above the age of 18 who have been fully vaccinated with Covishield or Covaxin vaccines can take Biological E Limited’s Corbevax as their booster or third shot.
June 4, 2022
Hyderabad-based Pharmaceuticals firm Biological E Ltd (BE) on Saturday announced that its Covid-19 vaccine Corbevax has been cleared by the Drugs Controller General of India (DCGI) as a heterologous Covid-19 booster for 18 plus population after ...
May 24, 2022
In Tokyo, President Biden, Prime Minister Anthony Albanese of Australia, Prime Minister Modi of India, and Prime Minister Kishida of Japan will advance
May 17, 2022
NEW DELHI, May 16:Pharmaceuticals firm Biological E. Ltd (BE) on Monday said it has reduced the price of its COVID-19 vaccine Corbevax to Rs 250 from Rs 840 a dose, inclusive of GST, for private vaccination centres. It would result in end users paying a price of Rs 400 a dose, including taxes and administration charges, the company said in a statement. Previously, in private vaccination centres the overall cost to end users of the vaccine was Rs 990 a […]